SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 3.23 |
| Enterprise Value ($M) | 2.07 |
| Book Value ($M) | 0.36 |
| Book Value / Share | 0.21 |
| Price / Book | 8.88 |
| NCAV ($M) | -1.38 |
| NCAV / Share | -0.81 |
| Price / NCAV | -2.34 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -8.70 |
| Return on Assets (ROA) | -1.95 |
| Return on Equity (ROE) | -3.44 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.72 |
| Current Ratio | 0.72 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 2.10 |
| Assets | 3.84 |
| Liabilities | 3.48 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 4,475 | 31,728 | 14.10 | |
| 14,617 | 79,308 | 18.43 | |
| 85,777 | 351,870 | 24.38 | |
| 44,400 | 114,485 | 38.78 | |
| 9,634 | 26,587 | 36.24 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| UPC – Universe Pharmaceuticals INC | UPXI – Upexi, Inc. |
| VERU – Veru Inc. | VKTX – Viking Therapeutics, Inc. |
| VSTM – Verastem, Inc. |
Financial data and stock pages provided by
Fintel.io